Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lexeo Therapeutics, Inc. Common Stock
Market Cap
$259.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$259.14M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$259.49M
Operating Margin
-26.17%
TTM Avg
-26.03%
3Y Avg
-26.03%
5Y Avg
-20.02%
Market Cap
$259.56M
Operating Margin
-59.23%
TTM Avg
-35.16%
3Y Avg
-14.58%
5Y Avg
-11.13%
Market Cap
$258.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1307.00%
5Y Avg
-871.33%
Market Cap
$261.27M
Operating Margin
-247.44%
TTM Avg
-835.51%
3Y Avg
-417.75%
5Y Avg
-611.14%
Market Cap
$261.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$256.47M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$255.88M
Operating Margin
-4.24%
TTM Avg
-7.03%
3Y Avg
-2.53%
5Y Avg
-5.01%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. Common Stock (LXEO) | $259.12M | 0.00% | 0.00% | 0.00% | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | -26.17% | -26.03% | -26.03% | -20.02% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | -59.23% | -35.16% | -14.58% | -11.13% |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 0.00% | 0.00% | -1307.00% | -871.33% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -247.44% | -835.51% | -417.75% | -611.14% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| AC Immune S.A. (ACIU)vs › | $256.47M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | -4.24% | -7.03% | -2.53% | -5.01% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -59.68% | -91.28% | -192.69% | -176.13% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | -3292.28% |
| 2022-06-30 | -41381.08% |
| 2022-03-31 | -14633.85% |
